(Q40040714)

16 September 2017

Vpr.A3A chimera inhibits HIV replication (English)

1 reference

16 September 2017

3

Amilcar Tanuri

1 reference

16 September 2017

Renato S Aguiar

1

1 reference

16 September 2017

Nika Lovsin

series ordinal

2

1 reference

16 September 2017

B Matija Peterlin

series ordinal

4

1 reference

16 September 2017

language of work or name

English

0 references

publication date

5 December 2007

1 reference

Journal of Biological Chemistry

16 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 September 2017

283

1 reference

16 September 2017

2518-2525

1 reference

16 September 2017

5

1 reference

Retroviral restriction by APOBEC proteins

16 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

APOBEC-mediated viral restriction: not simply editing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Multifaceted antiviral actions of APOBEC3 cytidine deaminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

APOBEC3 inhibits mouse mammary tumour virus replication in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Reconstitution of an infectious human endogenous retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

APOBEC3 proteins inhibit human LINE-1 retrotransposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Complementation of integrase function in HIV-1 virions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

The Vpr protein from HIV-1: distinct roles along the viral life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

A conserved mechanism of retrovirus restriction in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

DNA deamination mediates innate immunity to retroviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

Trim5alpha protein restricts both HIV-1 and murine leukemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706436200

21 January 2018

Identifiers

DOI

10.1074/JBC.M706436200

1 reference

16 September 2017

1 reference